{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:58:05Z","timestamp":1772121485757,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ophtha.2011.09.008","type":"journal-article","created":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T20:40:34Z","timestamp":1325796034000},"page":"494-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Intralesional Interferon-\u03b1 for Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma"],"prefix":"10.1016","volume":"119","author":[{"given":"Maria Antonietta","family":"Blasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra C.","family":"Tiberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Laguardia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Sammarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Balestrazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi M.","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Balestrazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.09.008_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","article-title":"Occurrence and prognosis of extranodal lymphomas","volume":"29","author":"Freeman","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2011.09.008_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.84.8.907","article-title":"Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival","volume":"84","author":"Jenkins","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/archopht.125.12.1668","article-title":"Lymphoproliferative diseases of the ocular adnexa in Korea","volume":"125","author":"Oh","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib4","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","article-title":"Classification of lymphoid neoplasms: the microscope as a tool for disease discovery","volume":"112","author":"Jaffe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2011.09.008_bib5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djj248","article-title":"Rapidly increasing incidence of ocular non-Hodgkin lymphoma","volume":"98","author":"Moslehi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2011.09.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1755-3768.2008.01478.x","article-title":"Ophthalmic lymphoma: epidemiology and pathogenesis","volume":"87","author":"Sj\u00f6","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","article-title":"Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci","volume":"107","author":"Rosado","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2011.09.008_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2011.09.008_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0161-6420(01)00547-4","article-title":"Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.008_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/10428190500518966","article-title":"Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors","volume":"47","author":"Meunier","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ophtha.2011.09.008_bib11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/archopht.125.12.1663","article-title":"Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma","volume":"125","author":"Hatef","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0360-3016(84)90172-X","article-title":"Radiation therapy of conjunctival and orbital lymphoid tumors","volume":"10","author":"Jereb","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2011.09.008_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2011.09.008_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2008.09.011","article-title":"Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma","volume":"90","author":"Nam","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1023\/A:1008327301372","article-title":"Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa","volume":"9","author":"Baldini","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ophtha.2006.01.057","article-title":"Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit","volume":"113","author":"Ben Simon","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.008_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/annonc\/mdm457","article-title":"Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma","volume":"19","author":"Song","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10792-007-9102-5","article-title":"Localized conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma is amenable to local chemotherapy","volume":"28","author":"Yu","year":"2008","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djj373","article-title":"Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial","volume":"98","author":"Ferreri","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2011.09.008_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2141.2010.08179.x","article-title":"Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial [letter]","volume":"150","author":"Govi","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0161-6420(00)00591-1","article-title":"Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report","volume":"108","author":"Blasi","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.008_bib22","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.leukres.2008.05.018","article-title":"Conjunctival MALT lymphoma successfully treated with single agent rituximab therapy [letter, report online]","volume":"33","author":"Salepci","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.ophtha.2011.09.008_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdn692","article-title":"Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma","volume":"20","author":"Esmaeli","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib24","first-page":"284","article-title":"Treatment of conjunctival mucosa-associated lymphoid tissue lymphoma with intralesional injection of interferon alfa-2b","volume":"118","author":"Lachapelle","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ajo.2004.05.004","article-title":"Systemic remission of non-Hodgkin's lymphoma after intralesional interferon alpha-2b to bilateral conjunctival lymphomas","volume":"138","author":"Ross","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib26","first-page":"1860","article-title":"Report of the Committee on Hodgkin's Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.ophtha.2011.09.008_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.leu.2404479","article-title":"Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets: report of the BIOMED-2 Concerted Action BHM4-CT98\u20133936","volume":"21","author":"Evans","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.ophtha.2011.09.008_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ophtha.2011.09.008_bib29","first-page":"555","article-title":"Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa","volume":"40","author":"Coupland","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.09.008_bib30","first-page":"1270","article-title":"Conjunctiva-associated lymphoid tissue in the human eye","volume":"41","author":"Knop","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.09.008_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.survophthal.2008.04.008","article-title":"The role of infectious agents in the etiology of ocular adnexal neoplasia","volume":"53","author":"Verma","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ophtha.2006.09.020","article-title":"Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma","volume":"114","author":"Sj\u00f6","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.008_bib33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/bjo.2007.132316","article-title":"The association between conjunctival MALT lymphoma and Helicobacter pylori","volume":"92","author":"Lee","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2011.09.008_bib35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","article-title":"Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions","volume":"209","author":"Chanudet","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.pas.0000249445.28713.88","article-title":"Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci","volume":"31","author":"Ruiz","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1532\/IJH97.06065","article-title":"Absence of chlamydial infection in Japanese patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue","volume":"85","author":"Yakushijin","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib38","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.leukres.2005.12.003","article-title":"No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from the Netherlands","volume":"30","author":"Mulder","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.ophtha.2011.09.008_bib39","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.4049\/jimmunol.179.10.6881","article-title":"Targeting IFN-alpha to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities","volume":"179","author":"Huang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01850","article-title":"Integration of interferon-alpha\/beta signalling to p53 responses in tumour suppression and antiviral defense","volume":"424","author":"Takaoka","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ophtha.2011.09.008_bib41","first-page":"5155","article-title":"Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses","volume":"47","author":"Sidky","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.ophtha.2011.09.008_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ijc.2910610119","article-title":"Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha","volume":"61","author":"Rodriguez-Villanueva","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ophtha.2011.09.008_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1359-6101(01)00022-3","article-title":"Interferon-alpha in tumor immunity and immunotherapy","volume":"13","author":"Belardelli","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ophtha.2011.09.008_bib44","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.0901329106","article-title":"Impaired interferon signaling is a common immune defect in human cancer","volume":"106","author":"Critchley-Thorne","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2011.09.008_bib45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2011.09.008_bib46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/annonc\/mdj143","article-title":"\u2018Blind\u2019 antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa","volume":"17","author":"Grunberger","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0609.2004.00299.x","article-title":"Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva","volume":"73","author":"Nuckel","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ophtha.2011.09.008_bib48","first-page":"1578","article-title":"Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa","volume":"90","author":"Ferreri","year":"2005","journal-title":"Haematologica"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011008438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011008438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:02:40Z","timestamp":1758981760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011008438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0161642011008438"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14253968.15768071","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intralesional Interferon-\u03b1 for Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}